A gentle introduction to understanding preclinical data for cancer pharmaco-omic modeling

Area of Science:

• Oncology
• Bioinformatics
• Computational Biology

Background:

• Precision oncology seeks to personalize cancer treatment strategies.
• Preclinical research often involves molecular and drug response characterization of patient tumors.
• In silico modeling, particularly machine learning, is a key tool for predicting treatment efficacy.

Purpose of the Study:

• To introduce scientists to the generation of datasets for predictive modeling in precision oncology.
• To explain the underlying principles of molecular and drug response data in cancer research.
• To provide a foundational understanding for researchers new to the field.

Main Methods:

• Review of existing literature and methodologies in precision oncology data generation.
• Explanation of tumor molecular profiling techniques.
• Overview of drug response assays and data collection.

Main Results:

• Detailed explanation of how molecular and drug response data are generated.
• Discussion on the sources of variability within these datasets.
• Identification of key factors influencing dataset characteristics.

Conclusions:

• Understanding dataset generation is crucial for effective in silico modeling in precision oncology.
• This review serves as an introductory guide for scientists entering the field.
• Accurate data characterization is fundamental for advancing personalized cancer therapies.